Painel Hipofisário de Rato
Descrição: MILLIPLEX MAP Human Pituitary Panel - 7 Plex
Informação: Este ensaio multiplex pode ser utilizado para a determinação quantitativa simultânea dos seguintes hormônios hipofisários de rato em qualquer combinação: GH, TSH, ACTH, LH, Prolactin, FSH, e BDNF.
Aplicação: 25 µL amostra - ensaio overnight - diluição 1:3 para soro e plasma.
Reatividade: Rato
Precisão, %:
- Inter-ensaio: < 15
- Intra-ensaio: < 9.5
Sensibilidade:
- GH 12.0 pg/mL
- TSH 6.4 pg/mL
- ACTH 2.1 pg/mL
- LH 4.9 pg/mL
- PRL 9.0 pg/mL
- FSH 47.7 pg/mL
- BDNF 0.4 pg/mL
Áreas Terapêuticas:
- Diabetes
- Obesidade
- Desordens Metabólicas
Linearidade de Diluição:
- GH 117%
- TSH 114%
- ACTH 92%
- LH 130%
- PRL 115%
- FSH 109%
- BDNF 118%
Exatidão:
- GH 95%
- TSH 93%
- ACTH 99%
- LH 85%
- PRL 96%
- FSH 99%
- BDNF 114%
Intervalo de Curva Padrão:
Métodos de Detecção: Luminex xMAP
Tipo de Ensaio: Multiplex
*Somente para pesquisa, não é destinado ao uso terapêutico ou diagnóstico
DOCUMENTO
REFERÊNCIA
Chronic ethanol ingestion, type 2 diabetes mellitus, and brain-derived neurotrophic factor (BDNF) in rats.
| Author | Jung KI, Ju A, Lee HM, Lee SS, Song CH, Won WY, Jeong JS, Hong OK, Kim JH, Kim DJ |
| Citation Information | Neurosci Lett, : (2010) |
| Related Products | RPT86K |
| Pub Med ID | 20946939 |
Abstract
Chronic alcohol consumption contributes to the development of type 2 diabetes mellitus (T2DM) while decreasing the level of brain-derived neurotrophic factor (BDNF). BDNF may be an important regulator of glucose metabolism, so it may be associated with an increased risk for T2DM in alcoholism. We evaluated the association of chronic heavy alcohol exposure, T2DM and BDNF level. Ten week-old type 2 diabetic OLETF rats and non-diabetic LETO rats of similar weight were used. The rats were randomized by weight into four treatment groups: (1) OLETF-Ethanol (O-E, n=13), (2) OLETF-Control (O-C, n=15), (3) LETO-Ethanol (L-E, n=11), and (4) LETO-Control (L-C, n=14). The ethanol groups were fed an isocaloric liquid diet containing ethanol while the control groups were fed with the same diet containing maltose-dextran over a 6-week period using a pair-feeding control model in order to regulate different caloric ingestion. After 6 weeks of feeding, an Intraperitoneal Glucose Tolerance Test (IP-GTT) was performed and BDNF levels were analyzed. Prior to IP-GTT, the mean glucose levels in the O-E, O-C, L-E, and L-C groups were 90.38±12.84, 102.13±5.04, 95.18±6.43, and 102.36±4.43mg/dL, respectively. Thirty minutes after intraperitoneal injection, the mean glucose levels were 262.62±63.77, 229.07±51.30, 163.45±26.63, and 156.64±34.42mg/dL, respectively; the increased amount of the mean glucose level in the O-E group was significantly higher than that in the O-C group (p<0.05). One hundred twenty minutes after intraperitoneal injection, the mean glucose levels were 167.38±45.37, 121.20±18.54, 106.73±6.94, and 104.57±9.49mg/dL, respectively; the increased amount of the mean glucose level in the O-E group was significantly higher than that in the O-C group (p<0.01). The difference in mean glucose levels between the O-E group and O-C group was still significant even after adjusting for time (p<0.05). Mean BDNF levels were 405.95±326.16, 618.23±462.15, 749.18±599.93, and 1172.00±839.17pg/mL, respectively; mean BDNF level in the O-E group was significantly lower than the L-C group (p<0.05). In conclusion, the results of the present study suggest that chronic heavy alcohol ingestion may aggravate T2DM and may possibly lower BDNF level.
Brochura
MILLIPLEX MAP and the Endocrine System Luminex xMAP Technology
| Código do Produto | RPT86K |
|---|---|
| Tipo de Produto | Multiplex MILLIPLEX - Endócrino |
| Fornecedor | MILLIPORE |
| Quantidade | 96 testes ![]() |
| Espécie | Rato |
| Clique aqui para mais informações | |
| Solicitar Cotação |


Copyright 1992-2011 Genese Produtos Diagnósticos Ltda